Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Eterna Therapeutics logo — Laser Focus with Relentless Execution

Eterna Therapeutics

Laser Focus with Relentless Execution

Founded 1994 United States Cambridge, United States 5 employees Post Ipo Debt Total: $49.08M Biotechnology, Health Care +2

General Information

Company Name Eterna Therapeutics
Founded Year 1994
Location United States Cambridge, United States +1
Employees 5
Industries Biotechnology, Health Care, Health and Wellness +1
Funding Stage Post Ipo Debt
Social

Get notified when Eterna Therapeutics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Eterna Therapeutics

Eterna Therapeutics, established in 1984, is a biotechnology and pharmaceutical company headquartered in the United States. The company is focused on developing transformative medicines to address various forms of cancer and other diseases with high unmet medical needs. Utilizing breakthrough mRNA cell engineering technologies, Eterna Therapeutics aims to repair cellular dysfunction and provide treatment for a range of therapeutic indications. Through strategic partnerships, the company is advancing innovative nucleic acid and cell therapies to significantly improve the health outcomes of patients. With a commitment to ensuring access to effective treatments for serious illnesses, Eterna Therapeutics is dedicated to creating a world where patients and their families can benefit from life-changing therapies. The company recently secured a $9.20M post-IPO debt investment on 14 December 2023.

Taxonomy: mRNA cell engineering, nucleic acid therapies, cell therapies, immune system restoration, cancer treatment, therapeutic indications, human derived cytokines, gene editing, non-viral nucleic acid delivery, cellular reprogramming

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Post-IPO Debt •••••• - 14 Dec 2023
Post-IPO Debt •••••• - 18 Jul 2023
Post-IPO Equity •••••• 1
Investor
11 Apr 2023
Post-IPO Equity •••••• - 06 Nov 2018

Eterna Therapeutics Alternatives & Competitors

Eterna Therapeutics vs
Mirus Bio
Mirus Bio United States

The Transfection Experts

59 employees
Biotechnology, Health Care
Eterna Therapeutics vs
Autolus Therapeutics
Autolus Therapeutics United Kingdom

Focused on the development of precisely targeted, controlled & highly active T cell therapies for ca...

Post Ipo Equity
763 employees
Biopharma, Biotechnology
Eterna Therapeutics vs
Anjarium Biosciences AG
Anjarium Biosciences AG Switzerland

DNA to Catalyze Your Advanced Therapies

Series A
15 employees
Biotechnology, Pharmaceutical

FAQ About Eterna Therapeutics

Laser Focus with Relentless Execution
Eterna Therapeutics was founded in 1994.
Eterna Therapeutics is headquartered in Cambridge, United States.
Eterna Therapeutics operates in the following industries: Biotechnology, Health Care, Health and Wellness, Pharmaceutical.
Eterna Therapeutics has approximately 5 employees.
Eterna Therapeutics has completed 4 funding rounds, raising a total of $49.08M. The latest funding stage is Post Ipo Debt.
Top alternatives and competitors to Eterna Therapeutics include Mirus Bio, Autolus Therapeutics, Anjarium Biosciences AG, iCamuno Biotherapeutics Pty Ltd, DeNovix Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Eterna Therapeutics and Mirus Bio are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Eterna Therapeutics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy